Covered recipient · General Payments record
CHRISTIAAN HALLMAN
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2023–2024
$713.50
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $256.76 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $49.79 | 1 |
| Endogastric Solutions, Inc | $37.68 | 1 |
| Regeneron Healthcare Solutions, Inc. | $34.12 | 1 |
| Octapharma USA, Inc. | $33.99 | 1 |
| Janssen Biotech, Inc. | $31.13 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.04 | 1 |
| ABBVIE INC. | $24.89 | 1 |
| Lilly USA, LLC | $20.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.89 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867197 | CMS |
| Endogastric Solutions, Inc | $37.68 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144676832 | CMS |
| GENZYME CORPORATION | $49.79 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139927643 | CMS |
| Janssen Biotech, Inc. | $31.13 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078316906 | CMS |
| Lilly USA, LLC | $20.12 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136119105 | CMS |
| Octapharma USA, Inc. | $33.99 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142315184 | CMS |
| Regeneron Healthcare Solutions, Inc. | $34.12 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114063567 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.04 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152135402 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.